According to GlobalData’s medical device pipeline database, 89 Spinal Non-Fusion devices are in various stages of development globally. GlobalData’s report Spinal Non-Fusion provides an overview of the segment’s pipeline landscape and offers detailed analysis of its products. Buy the report here.
Smarter leaders trust GlobalData
Of these devices, 24 are in active development, while the remaining 65 are in an inactive stage of development. There are 11 products in the early stages of development, and the remaining 13 are in the late stages of development.
Orthopedic devices are medical devices that are used to treat or prevent musculoskeletal disorders. Spinal non-fusion surgery is performed to treat spinal instability, degenerative disc disorder and spinal stenosis while preserving the spine’s normal motion, load bearing, shock absorption capacity and to provide pain relief without major anatomical removal. The devices used in spinal non-fusion surgeries are Pedicle Screw-Based Dynamic Stabilization Systems, Interspinous Process Decompression (IPD) Devices, Artificial Disc Replacement (ADR) Systems which includes Cervical Total Disc Replacement Systems and Lumbar Total Disc Replacement Systems Facet. Arthroplasty refers to the implantation of a spinal prosthesis to restore posterior element structure and function as an adjunct to neural decompression. Annulus Repair Devices are implants which provide a similar structure to that of a healthy annulus preventing disc herniation. Artificial Disc Replacement offers an alternative to spinal fusion for the patients who have chronic back pain from degenerative disc disease. Interspinous Process Decompression is a surgical procedure in which an implant is placed between spinous processes in the back of the spine. Pedicle Screw-Based Dynamic stabilization systems include two components, one for attachment to a superior vertebra of a spinal motion market and the other for the attachment to an inferior vertebra of a spinal motion market.
Innovations in the medical devices sector are linked to the development of new approaches, processes, or technologies for treating, diagnosing, and managing disease in response to demand from healthcare for better patient outcomes and reduce healthcare costs.
Based on an analysis of GlobalData’s Medical Intelligence Center pipeline product database, these actively developed Spinal Non-Fusion pipeline devices are all expected to be approved within the next ten years.
Currently, private organizations, public entities and institutions are working on the development of Spinal Non-Fusion devices. Overall, most of these Spinal Non-Fusion pipeline devices are being developed by private entities.
Key players involved in the active development of Spinal Non-Fusion include ZimVie, SeaSpine, Orthonex, Medtronic, Meliora Medical, Aurora Spine, Disc Motion Technologies, NEOS Surgery, NEXUS TDR and Spine Wave.
For a complete picture of the developmental pipeline for Spinal Non-Fusion devices, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. The Pipeline Products database is a is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.
